Dante Labs Acquires Cambridge Cancer Genomics To Create Global Excellence In Precision Oncology

Jul 10, 2021

∙ Paid

Dante Labs, a leading genomics and diagnostics company, today announced the acquisition of Cambridge Cancer Genomics (CCG.ai), a groundbreaking Y-Combinator company & leader in machine learning for clinical oncology, to create a single platform with unparalleled capabilities in genomics and oncology data analysis.